List of insiders holdings for Kala Pharmaceuticals, Inc.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Holder NameReport
Date Time
Shares Owned
Directly
Indirectly
Total
Shares Owned
Filing
Grunberg Gregory
Director
2021-06-21 17:30:1840,000
5,411,860
5,451,860Form 4
RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
Kolchinsky Peter
Shah Rajeev M.
10% Owner
2022-06-03 17:11:233,412,868
0
3,412,868Form 13D
TEPPER ROBERT I
Director
2017-07-26 16:30:490
1,654,425
1,654,425Form 4
Lux Capital Management LLC
Lux Venture Associates II LLC
Lux Venture Partners II L.P.
Lux Ventures II Sidecar LP
Lux Ventures II L.P.
10% Owner
2017-07-19 17:35:340
1,289,067
1,289,067Form 3
CVF LLC
10% Owner
2017-07-19 17:23:391,190,787
0
1,190,787Form 3
CDK ASSOCIATES L.L.C.
CAXTON CORP
Kovner Bruce
10% Owner
2017-07-21 17:54:22763,755
0
763,755Form 4/A
Ysios BioFund I FCR
10% Owner
2017-07-19 17:32:11729,391
0
729,391Form 3
Hanes Justin
10% Owner
2017-07-19 18:14:16601,923
0
601,923Form 3
Polaris Venture Management Co. V L.L.C.
Polaris Venture Partners Entrepreneurs' Fund V L.P.
Polaris Venture Partners Founders' Fund V L.P.
Polaris Venture Partners Special Founders' Fund V L.P.
Polaris Venture Partners V L.P.
10% Owner
2020-02-12 16:55:02598,620
0
598,620Form 13G
Chen Hongming
CHIEF SCIENTIFIC OFFICER
2021-10-28 20:06:52204,515
0
204,515Form 4
Longitude Capital Partners II LLC
ENRIGHT PATRICK G
Tammenoms Bakker Juliet
Longitude Venture Partners II L.P.
10% Owner
2023-02-14 16:15:16108,239
0
108,239Form 13D
McDermott Charles Douglas
President and Chief Bus. Off.
10% Owner
2017-07-21 16:07:5286,056
0
86,056Form 3/A
KOVEN ANDREW I
Director
2022-06-17 16:45:1950,000
0
50,000Form 4
Paull Robert Bradley
Director
2022-06-17 16:45:2840,000
0
40,000Form 4
Myers C. Daniel
Director
2022-06-17 16:46:0140,000
0
40,000Form 4
Blumenkranz Mark S.
Director
2022-06-17 16:45:4640,000
0
40,000Form 4
Rosen Howard B
Director
2022-06-17 16:45:5540,000
0
40,000Form 4
PERRY GREGORY D
Director
2022-06-17 16:45:3840,000
0
40,000Form 4
LANGER ROBERT
Director
2018-06-15 10:50:5612,960
0
12,960Form 4
Hill Paulina
Director
2018-06-14 16:47:1312,960
0
12,960Form 4
LaRussa Michele
Sr. VP, Regulatory and Quality
2018-02-09 16:29:598000
0
8000Form 4
Farid Marjan
Director
2022-11-01 16:12:361600
0
1600Form 4
Iwicki Mark T
CHIEF EXECUTIVE OFFICER
2023-03-15 20:00:101512
0
1512Form 4
Bazemore Todd
SEE REMARKS
2023-03-15 20:00:13576
0
576Form 4
Brazzell Romulus K
SEE REMARKS
2023-03-15 20:00:15576
0
576Form 4
Reumuth Mary
CHIEF FINANCIAL OFFICER
2023-03-15 20:00:18432
0
432Form 4
Trachtenberg Eric
SEE REMARKS
2023-03-15 20:00:22432
0
432Form 4
Kharabi Darius
CHIEF BUSINESS OFFICER
2023-03-15 20:00:23432
0
432Form 4
Hadley Harbor Master Investors (Cayman) L.P.
10% Owner
2019-02-12 10:16:160
0
0Form 13G
ORBIMED ADVISORS LLC
OrbiMed Capital GP VI LLC
ISALY SAMUEL D
10% Owner
2021-10-14 17:00:520
0
0Form 13G
ORBIMED ADVISORS LLC
OrbiMed Capital GP VI LLC
10% Owner
2021-10-14 17:00:520
0
0Form 13G